freestyle libre flash glucose monitoring system for sale

The Freestyle Libre product introduced by Abbott Diabetes Care in 2015 was billed as 'Flash glucose monitoring,' and featured a sensor that was factory calibrated, not requiring recalibration against a finger-stick glucose test during use. This lag time varies based on the person and the device, and is generally 5–20 minutes. As it takes time for glucose to travel from the bloodstream into the interstitial fluid, there is an inherent lag behind the current blood glucose level and the level measured by the CGM. Īnother limitation is that glucose levels are taken from the interstitial fluid rather than the blood. Some manufacturers warn users of relying only on CGM-measurements and the National Institute for Health and Care Excellence recommends to validate hypoglycaemic values via fingerprick testing of blood glucose level.

Still, on the Cochrane systematic review mentioned above, the use of continuous glucose monitors did not increase the risk of hypoglycaemia or ketoacidosis. This is especially problematic as some devices offer alarm functions to warn of hypoglycemic episodes and people might rely on those alarms. However, there are important limitations: CGM systems are not sufficiently accurate for detecting hypoglycemia, a common side-effect of diabetes treatment. However, the use of continuous glucose monitors appears to lower hemoglobin A1c levels, more than just monitoring through capillary blood testing, particularly when used by individuals with poorly controlled diabetes together with an integrated insulin pump. Ī Cochrane systematic review found that there is limited and conflicting evidence of the effectiveness of continuous glucose monitoring systems in children, adults or patients with poorly controlled diabetes.

Some studies have demonstrated reduced time spent in hypoglycemia or a lower glycated hemoglobin, both favorable outcomes. ĬGM is an increasingly adopted technology which has shown to have benefits for people with diabetes. Users must calibrate CGM devices with traditional blood glucose measurements.

CGM use allows trends in blood glucose to be displayed over time. Traditional fingerprick testing of blood glucose levels measures the level at a single point in time. This electric current (proportional to the glucose concentration) is then relayed from a transmitter attached to the sensor out to a reader which displays the data to the patient. Currently approved CGMs use an enzymatic technology which reacts with glucose molecules in the interstitial fluid generating an electric current. A continuous glucose monitor consists of three parts: a small electrode placed under the skin, a transmitter sending readings at regular intervals (ranging from every 5 to 15 min), and a separate receiver. people with type I, type II diabetes or other types of diabetes (e.g. The sensor and transmitter are fixed to the upper arm and the receiver shows current blood glucose level and a graph of recent blood glucose levels.Ī continuous glucose monitor (CGM) is a device used for monitoring blood glucose on a continual basis by insulin-requiring people with diabetes, e.g. The product images are for illustrative purposes only.Abbott Laboratories' FreeStyle CGM. This website and the information contained herein is intended for use by residents of Singapore. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company. Other trademarks are the property of their respective owners. Please read the Legal Notice for further details.įreeStyle, Libre and related brand marks are trademarks of Abbott Diabetes Care Inc. Always read the label and use as directed.įor more information call Customer Service on 1 8 or +65 3138 3799. Health care professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any other groups of patients who require diabetes management. The indication for children (age 4 – 17) is limited to those who are supervised by a caregiver at least 18 years old who is responsible for supervising, managing, and assisting the child in using the FreeStyle Libre system and interpreting its readings. The FreeStyle Libre flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with diabetes mellitus.

Freestyle libre flash glucose monitoring system for sale